SLC30A1

Across TCGA pan-cancer cohorts, SLC30A1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of SLC30A1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where SLC30A1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types SLC30A1 is over-expressed in tumor, although a few such as CCRCC show the opposite, repressed pattern.

LUAD, LSCC, and HNSC are the cancer types where SLC30A1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC30A1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	III,IV	+0.662	<.001	9	view →
LSCC	Female	All	+0.445	<.001	9	view →
HNSC	Male	II,III,IV	+0.291	<.001	8	view →
CCRCC	All	All	−0.127	.002	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

SLC30A1–LUAD

Open the LUAD breakdown →